Patent: 9,492,499
✉ Email this page to a colleague
Summary for Patent: 9,492,499
Title: | Peptides having anti-inflammatory properties |
Abstract: | Aspects of the present invention relate to peptides having anti-inflammatory activity, compositions containing one or more of the peptides, and use of the peptides to treat conditions associated with excessive inflammation in animals, particularly humans and other mammals. |
Inventor(s): | Jaynes; Jesse M. (Auburn, AL), Lopez; Henry W. (Napa, CA), Martin; George R. (Rockville, MD), Yates; Clayton (Auburn, AL), Garvin; Charles E. (Redwood City, CA) |
Assignee: | Riptide Bioscience, Inc. (Vallejo, CA) |
Application Number: | 14/882,293 |
Patent Claims: | see list of patent claims |
Details for Patent 9,492,499
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2034-10-14 |
Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | 02/19/2002 | ⤷ Try a Trial | 2034-10-14 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2034-10-14 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2034-10-14 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |